Gabelli, Gamco report 5.39% combined stake in New River Pharmaceuticals

By Lisa Kerner

Charlotte, N.C., March 29 - New River Pharmaceuticals Inc. investors led by Gabelli Funds, LLC and Gamco Asset Management Inc. bought 2,065,000 shares of the company's stock between Feb. 20 and March 27 priced from $62.96 to $63.68 per share.

Gabelli Funds beneficially owns 680,000 shares, or 1.84%, and Gamco Asset Management owns 946,200 shares, or 3.55%, of the company's stock, according to a schedule 13D filing with the Securities and Exchange Commission. In total, the companies and their affiliates own 2,080,200 shares, or 5.61%, of New River's stock.

New River is a specialty pharmaceutical company located in Radford, Va.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.